Carl Zeiss Meditec AG

1AFX

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,784

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,880.6049.30-0.55%
CAC 408,131.716.830.08%
DAX 4024,168.3661.55-0.25%
Dow JONES (US)48,416.5641.49-0.09%
FTSE 1009,720.3830.93-0.32%
HKSE25,235.41393.47-1.54%
NASDAQ23,057.41536.44-2.27%
Nikkei 22549,383.29784.82-1.56%
NZX 50 Index13,424.9516.810.13%
S&P 5006,816.5110.90-0.16%
S&P/ASX 2008,598.9048.40-0.56%
SSE Composite Index3,824.8143.11-1.11%

Market Movers